Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

1.87
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
1.77
Today|||52-Week Range
6.50
-70.22%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close1.87
Today’s open1.86
Day’s range1.85 - 1.94
Volume75,220
Average volume (3 months)328,990
Market cap$51.5M
Dividend yield--
Data as of 4:00pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+62.50%
Earnings growth (this year)-4.86%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.74

Competitors

 Today’s
change
Today’s
% change
OCRXOcera Therapeutics I...+0.05+2.27%
AVIRAviragen Therapeutic...0.000.00%
APDNApplied DNA Sciences...-0.05-2.22%
ITUSITUS Corp-0.10-1.82%
Data as of 4:00pm ET, 12/05/2016

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$19.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs